Previous Close | 252.12 |
Open | 250.19 |
Bid | 245.00 x 1000 |
Ask | 250.35 x 1000 |
Day's Range | 245.39 - 251.98 |
52 Week Range | 200.32 - 290.20 |
Volume | |
Avg. Volume | 676,123 |
Market Cap | 23.938B |
Beta (5Y Monthly) | 1.07 |
PE Ratio (TTM) | 9.30 |
EPS (TTM) | 26.89 |
Earnings Date | Feb 08, 2023 - Feb 13, 2023 |
Forward Dividend & Yield | 2.88 (1.25%) |
Ex-Dividend Date | Nov 16, 2022 |
1y Target Est | 292.92 |
Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in the fourth quarter of 2022.
Henry Schein's (HSIC) dental business is likely to have gained in Q4 from the acquisition of Midway Dental.
Edwards Lifesciences (EW) continues to register strong momentum in TMTT, led by the continued adoption of the PASCAL platform in Europe.